From April 1, 2024 to June 30, 2024, the company has repurchased 1,354,900 shares, representing 1.73% for CNY 32.11 million. With this, the company has completed the repurchase of 4,036,458 shares, representing 5.05% for CNY 93.42 million under the buyback announced on February 29, 2024.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Equities
301130
CNE1000058C4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.11 CNY | -3.31% |
|
-0.22% | -17.11% |
1st Jan change | Capi. | |
---|---|---|
-17.11% | 249M | |
+62.97% | 856B | |
+39.19% | 631B | |
-3.73% | 359B | |
+18.22% | 325B | |
+9.23% | 297B | |
+5.89% | 234B | |
+16.76% | 226B | |
+16.60% | 177B | |
+2.38% | 165B |
- Stock Market
- Equities
- 301130 Stock
- News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
- Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.